Newsroom

Our mission is to provide innovative, blood-based diagnostics that change medical practice and improve the lives of patients with lung cancer.

A Molecular Diagnostics Company at the Forefront of Oncology Innovation

We discover, develop and deliver blood-based diagnostics to answer unmet clinical questions across the continuum of lung cancer and improve the standard of care for patients.

In addition to our on-market products, we collaborate with biopharma to help optimize their clinical development programs with blood-based diagnostics. Keep abreast of the exciting developments from Biodesix that supports the continuum of lung cancer.